29.09.2020 • NewsWeylChemPeople

WeylChem Appoints Johannes Kanellakopoulos as Head of Marketing & Sales Custom Manufacturing

WeylChem has appointed Johannes Kanellakopoulos as new Head of Marketing & Sales for its growing Custom Manufacturing business. He took over the role on Sept. 1 with the aim of fully exploiting the group's capabilities.

After studying chemistry in Germany and France and obtaining his PhD, Kanellakopoulos began his career in 1990 at Bayer as a lab manager in crop protection research. He first came into contact with custom manufacturing as plant manager in charge of piloting and initial production of customer-specific pharmaceutical intermediates. After further positions in marketing for exclusive synthesis, he became head of the newly created Global Strategic Sourcing unit in the Crop Protection division. When he moved to BASF, he took over the position of Head Sourcing & Contracting, where he was responsible for the global chemicals purchasing portfolio in the Agricultural Products division with a focus on outsourcing. Most recently, he was Manager Site Services at W.R. Grace’s site at Worms, Germany.

WeylChem has appointed Johannes Kanellakopoulos as new Head of Marketing &...
WeylChem has appointed Johannes Kanellakopoulos as new Head of Marketing & Sales for its growing Custom Manufacturing business. © WeylChem

Company

Logo:

WeylChem International GmbH

Alt-Fechenheim 34
60386 Frankfurt
Germany

Company contact







Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.